) is a major target for phosphorylation mediated by both PKA (at Ser68) and PKC (at both Ser63 and Ser68) in the heart. In intact cardiac myocytes, PLM associates with and inhibits Na ϩ -K ϩ -ATPase (NKA), mainly by reducing its affinity for internal Na ϩ . The inhibition is relieved upon PLM phosphorylation by PKA or PKC. The aim here was to distinguish the role of the Ser63 and Ser68 PLM phosphorylation sites in mediating kinase-induced modulation of NKA function. We expressed wild-type (WT) PLM and S63A, S68A, and AA (Ser63 and Ser68 to alanine double mutant) PLM mutants in HeLa cells that stably express rat NKA-␣ 1 and we measured the effect of PKA and PKC activation on NKA-mediated intracellular Na ϩ concentration decline. PLM expression (WT or mutant) significantly decreased the apparent NKA affinity for internal Na ϩ and had no significant effect on the maximum pump rate (V max). PKA activation with forskolin (20 M) restored NKA Na ϩ affinity in cells expressing WT but not AA PLM and did not affect V max in either case. Similarly, PKC activation with 300 nM phorbol 12,13-dibutyrate increased NKA Na ϩ affinity in cells expressing WT, S63A, and S68A PLM and had no effect in cells expressing AA PLM. Neither forskolin nor phorbol 12,13-dibutyrate affected NKA function in the absence of PLM. We conclude that PLM phosphorylation at either Ser63 or Ser68 is both necessary and sufficient for completely relieving the PLM-induced NKA inhibition.
PHOSPHOLEMMAN (PLM) WAS FIRST REPORTED as an important phosphorylation substrate for both PKA and PKC (13, 17, 18) in the heart; however, its physiological role was poorly understood. More recent studies (4, 5, 21) indicate that PLM belongs to a family of proteins (FXYD gene family) that bind specifically to and regulate the Na ϩ -K ϩ -ATPase (NKA) in various tissues. PLM is the only FXYD protein highly expressed in the heart and is unique among the FXYD proteins in that it has multiple phosphorylation sites in the cytoplasmic domain.
PLM associates specifically and stably with rat NKA ␣ 1 -, ␣ 2 -, and ␣ 3 -isoforms and reduces their apparent affinity for intracellular Na ϩ and extracellular K ϩ when coexpressed in oocytes (4) . We (6, 11) have previously shown that PLM reduces the NKA activity, mainly by reducing the apparent pump affinity for internal Na ϩ , in intact cardiac myocytes. PLM phosphorylation relieves this inhibition and thus mediates the PKA/PKCdependent stimulation of NKA (2, 6, 11) . Biochemical studies (10) indicate that PKA phosphorylates PLM mostly at the Ser68 site (although some phosphorylation also occurs at the Ser63 site) and PKC phosphorylates both Ser63 and Ser68 sites. Removal of these phosphorylation sites in the shark PLM-like protein restores the apparent Na ϩ affinity of the NKA (14, 15) . NKA is strongly stimulated in sarcolemmal membranes isolated from ischemic rat hearts compared with the controls, and this is accompanied by activation of PKA and PKC and subsequent phosphorylation of PLM (but not of the NKA ␣-subunit; Ref. 9) . PKA activation by forskolin resulted in PLM phosphorylation at Ser68 and significantly increased the Na ϩ pump current in isolated guinea-pig cardiac myocytes (20) . PKC activation also increases the maximum Na ϩ extrusion rate of the NKA ␣ 2 -isoform in mouse ventricular myocytes (6, 11) . Furthermore, the PKA-and PKC-dependent effects on NKA and the phosphorylation state of Ser63 and Ser68 are additive (11) , suggesting that the PKA/PKC-dependent pathways are independent in terms of NKA regulation. Thus the aim of this study was to investigate the role of PLM phosphorylation sites (Ser63 and Ser 68) in modulating NKA function. We measured the effect of PKA/PKC activation on the NKAmediated intracellular Na ϩ concentration ([Na ϩ ] i ) decline in HeLa cells overexpressing rat NKA-␣ 1 and determined how expression of PLM [wild type (WT) and its mutants] affect NKA regulation by PKA and PKC.
MATERIALS AND METHODS

Construction of viral vectors.
For this study, we used WT canine PLM and the following PLM mutants: Ser63 to Ala (S63A), Ser68 to Ala (S68A), and Ser63/Ser68 to Ala double mutant (AA PLM). The Ser to Ala mutation rendered the respective site unphosphorylatable. The WT and mutant PLM was obtained by cleaving GFP from the PLM-GFP plasmid vector using standard molecular biology methods. They were then subcloned into the pShuttle CMV vector. Adenoviruses were generated with AdEasy Vector system according to the manufacturer's instructions (Stratagene). After amplification, the virus was purified on a CsCl gradient and stored at Ϫ80°C.
HeLa cell culture and expression of PLM mutants. HeLa cells stably expressing the ouabain-resistant rat NKA-␣ 1 (a generous gift from Dr. Joshua Berlin, University of Medicine and Dentistry of New Jersey-New Jersey Medical School; Ref. 18) were maintained in DMEM with 5% FBS, penicillin/streptomycin, and 1 M ouabain. The medium was replaced every 3 days, and the cells were split via mild trypsinization when confluent. Twenty-four hours before experiments, cells were plated on a 25 ϫ 25 coverslip with a total of 5 ml medium in a culture dish (2% FBS). PLM WT and phosphorylationsite mutants were expressed in these HeLa cells by exposure to the appropriate adenovirus at a multiplicity of infection of 10 -50.
Confocal microscopy. Perfusion chambers containing the cultured cells on the coverslips were mounted on the stage of an inverted microscope. Confocal images were measured with a ϫ40 oil immer-sion objective lens. For GFP measurements, excitation was at 488 nm (Ͻ 5%) and emission was recorded at 520 nm.
Western blot. HeLa cells were lysed in ice-cold buffer containing 1% NP-40 and the following (in mmol/l): 150 NaCl, 10 Tris (pH 7.4), 2 EGTA, 50 NaF, 0.2 NaVO3, and protease inhibitors (Calbiochem). Lysates were size fractionated on 15% SDS-PAGE. Proteins were transferred to 0.20 m nitrocellulose membranes and blocked in 5% nonfat dry milk in TBS-Tween for 2 h at room temperature. The blots were then incubated overnight at 4°C with custom-made primary antibodies (1:5,000 dilution) that detect total PLM (C2 antibody), PLM phosphorylated at Ser 68 (CP68), or PLM phosphorylated at Ser 63 (CP63; a kind gift from Dr. Randall Moorman, University of Virginia; Ref. 20) .
PLM dephosphorylation was performed as previously described (3): 100 g of cell lysate were dephosphorylated with 0.3 U PP2A and 0.3U PP1 (from Calbiochem) for 20 min at 37°C in reaction buffer containing 50 mM Tris·HCl, 1 mM dithiotreitol, and 1 mM MgCl2 (pH 7.5). The reaction was terminated by the addition of 1 M microcystin-LR (a control reaction was also included that was preincubated with microcystin-LR for 10 min).
Intracellular [Na ϩ ]i measurements in HeLa cells. Cells were incubated with 10 M sodium-binding benzofuran isophthalate (SBFI)-AM in the presence of Pluronic F-127 (0.05% wt/vol) for 90 min at room temperature. After the external dye was washed out, SBFI-AM was allowed to further deesterify for 20 min in normal Tyrode solution. Dual excitation measurements (at 340 and 380 nm; F340 and F380) were performed on selected area for a group of ϳ20 cells (7) . The F340-to-F380 ratio was calculated after background subtraction and converted to [Na ϩ ]i by calibration at the end of each experiment (using divalent-free solutions with 0, 10, or 20 mM extracellular [Na ϩ ]) in the presence of 10 M gramicidin and 100 M strophanthidin (7). All measurements were at room temperature. Na ϩ efflux through the NKA. NKA-mediated Na ϩ efflux was determined as the rate of pump-mediated [Na ϩ ]i decline (7) . Myocytes were Na ϩ loaded by inhibiting the NKA in a K ϩ -free solution containing the following (in mM): 145 NaCl, 2 EGTA, 10 HEPES, and 10 glucose (pH 7.4). [Na ϩ ]i decline was measured upon pump reactivation in a solution containing the following (in mM): 130 TEA-Cl, 15 KCl, 1 MgCl2, 2 EGTA, 10 HEPES, and 10 glucose (pH 7.4). One micromolar of ouabain was used in most experiments to inhibit the endogenous human NKA. Since cell volume does not change with this protocol (8) Statistical analysis. Data are expressed as means Ϯ SE. Statistical discriminations were performed with Student's t-test (paired when appropriate) with P Ͻ 0.05 considered significant.
RESULTS
Measurement of NKA-mediated Na
ϩ efflux in HeLa cells. HeLa cells were loaded with SBFI and fluorescence was measured as described above. Fluorescence signals from a selected area of ϳ20 cells were recorded, and [Na ϩ ] i was calculated. Figure 1A shows a representative experiment where two [Na ϩ ] i loading/decline cycles were monitored under identical conditions to verify that consecutive control runs result in identical results. In all experiments, 1 M ouabain was used to block endogenous human NKA. A three-step calibration of the F340-to-F380 ratio was done at the end of the experiment. Similar to what we found in myocytes, consecutive control runs produce similar results (mean data not shown).
In parallel experiments, we measured the rate of Na ϩ pumpindependent Na ϩ efflux (leak) as the rate of [Na ϩ ] i decline in the presence of 10 mM ouabain, which blocks both the exogenous and endogenous NKA. The leak V max averages 2.0 Ϯ 0.3 mM/min and accounts for Ͻ25% of total Na ϩ efflux (Fig. 1B) . Furthermore, the leak component was not affected by application of forskolin or PDBu in HeLa cells (not shown). The leak component was subtracted from total Na ϩ efflux to calculate the rate of NKA-mediated Na ϩ efflux (Fig. 1B) . ϩ , Na ϩ -free solution. The protocol was then repeated under identical conditions to verify that consecutive control runs produce similar results; 1 M ouabain (Oua) was used throughout the experiment to inhibit the endogenous human NKA. A: 3-step calibration of the F340-to-F380 ratio was done at the end. B: contribution of the different efflux pathways to Na ϩ extrusion in HeLa cells. Na ϩ efflux measured in the presence of 1 M ouabain (NKA ϩ leak) is mediated by the expressed rat NKA-␣1 and NKA-independent pathways (leak component). The leak component (leak; measured in the presence of 10 mM ouabain) is small and not affected by application of either forskolin or phorbol 12,13-dibutyrate (PDBu) in HeLa cells. The difference between these 2 curves is the rate of Na ϩ efflux via the exogenous rat NKA-␣1 (NKA). Ϫd[Na ϩ ]i/dt is the rate of [Na ϩ ]i decline. The maximum Na ϩ extrusion rate of the pump (Vmax) and the [Na ϩ ]i for the half-maximal activation of the pump (K0.5) shown at right represent the values derived by fitting the curves at left with a Hill equation.
Effect of PLM expression on [Na ϩ
] i homeostasis in HeLa cells. The WT PLM and mutated PLM used in this study do not contain any fluorescent marker to avoid potential contamination of the SBFI fluorescence signal. In parallel control experiments, the adenoviral transduction efficiency of PLM-GFP is Ͼ90% as indicated in Fig. 2A . Western blot experiments showed a comparable level of heterologous PLM expression, whether PLM was expressed alone or in a vector that also contained GFP (Fig. 2B) . The noninfected (nonfluorescent) cells are displayed in a different layer and out of focus and are probably dead ( Fig. 2A) . Thus, during SBFI measurements, we selected areas that were devoid of out of focus and dead cells.
[ Na ϩ ] i and NKA-mediated Na ϩ efflux were measured 24 h after adenoviral infection of WT or mutant PLM. [Na ϩ ] i was 5.2 Ϯ 0.5 mM (n ϭ 12) in noninfected cells and significantly higher in HeLa cells expressing either WT or AA PLM (8.3 Ϯ 1.0, n ϭ 9, and 8.4 Ϯ 0.7 mM, n ϭ 10, respectively; Fig. 2C ). The higher [Na ϩ ] i in the presence of PLM is consistent with a decrease in Na ϩ efflux via NKA upon PLM association, as shown in myocyte studies (6) . Indeed, the total Na ϩ efflux curve is right shifted upon WT PLM expression (K 0.5 : 10.7 Ϯ 0.7 vs. 16.7 Ϯ 0.8 mM), without any significant change in the V max (7.9 Ϯ 0.7 vs. 8.2 Ϯ 0.6 mM). (Fig. 3 and Table 1 ). In the absence of PLM, forskolin did not significantly affect either V max (5.8 Ϯ 0.7 in control vs. 4.8 Ϯ 0.7 mM/min with forskolin; n ϭ 12), the apparent affinity of the pump for internal Na ϩ (K 0 Figure 3A shows the Na ϩ -activation curve normalized to V max to emphasize the lack of effect on K 0.5 . Heterologous expression of WT PLM significantly inhibited NKA by decreasing the apparent Na ϩ affinity (K 0.5 increased from 11.7 Ϯ 0.9 in cells without PLM to 18.5 Ϯ 0.7 mM with WT PLM; n ϭ 11; Fig. 3B ). Forskolin largely relieved NKA inhibition (K 0.5 significantly decreased to 13.8 Ϯ 1.2 mM; n ϭ 11). The NKA V max was similar in HeLa cells with and without PLM (5.6 Ϯ 0.6 vs. 5.8 Ϯ 0.7 mM/min) and was not affected by PKA activation (5.7 Ϯ 0.8 mM/min).
Expression of nonphosphorylatable AA PLM mutant (Ser68 and Ser63 to alanine double mutation) also decreased the apparent Na ϩ affinity of NKA (vs. NKA only) similar to WT PLM (K 0.5 ϭ 16.3 Ϯ 0.6 mM; n ϭ 10; Fig. 3C ). However, forskolin did not relieve NKA inhibition in HeLa cells expressing AA PLM (K 0.5 ϭ 16.0 Ϯ 0.8 mM). In addition, PKA activation did not change the V max or n H of NKA after AA PLM overexpression in HeLa cells (V max : 6.9 Ϯ 0.4 in control conditions vs. 6.1 Ϯ 0.5 mM/min with forskolin; n H : 2.8 Ϯ 0.2 vs. 2.6 Ϯ 0.1).
Overall, the data in HeLa cells are consistent with those in cardiac myocytes (2, 6), indicating that PLM inhibits NKA activity by decreasing its [Na ϩ ] i affinity and that this inhibitory effect is relieved by PKA phosphorylation of PLM phosphorylation sites. The nonphosphorylatable PLM works like a tonic inhibitor of NKA that cannot be relieved.
Effect of PKC activation on the NKA-mediated Na ϩ efflux in HeLa cells; role of PLM phosphorylation sites. We used the same method to determine the effect of PKC activation on NKA function in HeLa cells and the role of the different PKC phosphorylation sites on PLM in mediating this effect (Fig. 4) . PKC was activated with 300 nM PDBu. In the absence of PLM, PDBu failed to induce any changes in K 0.5 , V max , or n H (Fig. 4A and Table 1 ). This implies that PKC does not have a direct effect on NKA transport function under our experimental conditions here. PDBu increased the NKA Na ϩ affinity in cells expressing WT PLM (K 0.5 decreased from 16.3 Ϯ 1.4 mM in control condition to 13.4 Ϯ 1.1 mM with PDBu; n ϭ 9; Fig.  4B ) but not in cells expressing AA PLM (K 0.5 ϭ 17.6 Ϯ 1.3 vs. 17.7 Ϯ 1.6 mM; n ϭ 7; Fig. 4C ). PDBu had no effect on V max and n H . Thus PLM phosphorylation is required for the PKC effects on NKA activity.
WT PLM expressed in HeLa cells is readily phosphorylated by PKC at both Ser63 and Ser68 (similar to the situation in cardiac myocytes), as demonstrated using phosphorylationdependent antibodies (Fig. 5A) . There was also a variable degree of baseline phosphorylation at both S63 and S68 (see untreated column in Fig. 5B ). We investigated the separate effect of phosphorylation at each site on NKA function by mutating the other site to alanine. PDBu still induced phosphorylation of the S63A PLM mutant at Ser68 and of the S68A mutant at Ser63, as indicated by a 2-to 2.5-fold increase in the signal of the respective phospho-specific antibody ( Fig. 5C ; note that both alanine mutants display relatively high baseline signals, but these are independent of phosphorylation at that site). We expressed the Ser63A (Fig. 5D) or Ser68A (Fig. 5E ) PLM mutants in HeLa cells and measured the effect of PDBu on NKA-mediated Na ϩ efflux. Expression of either PLM decreased the apparent Na ϩ affinity of NKA, to a similar extent as seen with WT PLM. PKC activation by PDBu significantly increased the apparent Na ϩ affinity of NKA in both cases (K 0.5 decreases to 14.0 Ϯ 1.7 mM for Ser63A, n ϭ 9, and 13.9 Ϯ 1.3 mM for Ser68A, n ϭ 7). Thus PLM phosphorylation at either Ser68 or Ser63 can relieve the NKA inhibition by PLM to a similar extent and the effect does not seem additive.
DISCUSSION
The present study shows that heterologous PLM decreases internal Na ϩ affinity of rat NKA-␣ 1 stably expressed in HeLa cells. NKA inhibition results in a higher [Na ϩ ] i in the presence of PLM. PLM phosphorylation by PKA and PKC restores the NKA Na ϩ affinity and thus relieves the pump inhibition. PKA and PKC activation does not affect NKA function in HeLa cells without PLM or in cells expressing mutant PLM that has both Ser63 and Ser68 sites unphosphorylatable (by Ser to Ala mutations), indicating that these are the only major sites that mediate the PKA-and PKC-dependent effects on NKA. Phosphorylation of either Ser63 or Ser68 by PDBu is sufficient to relieve the PLM-dependent NKA inhibition.
PLM is unique within the FXYD family in that it has multiple phosphorylation sites in the cytoplasmic tail. We have previously shown that PLM phosphorylation mediates the PKA and PKC-dependent regulation of NKA in cardiac myocytes. However, the role of Ser63 and Ser68 phosphorylation sites in mediating these kinase-dependent effects (K 0.5 vs. V max ) is not fully understood. Phosphorylation of PLM at Ser68 mediates the PKA-dependent increase in the Na ϩ affinity of both NKA ␣ 1 -and ␣ 2 -isoforms in mouse ventricular myocytes (2) and oocytes (1) . PKC activation also increased PLM-dependent Na ϩ affinity of both NKA ␣ 1 -and ␣ 2 -isoforms, while increasing the V max of NKA-␣ 2 (2) . However, a role for PLM phosphorylation at the Ser63 site in relieving the NKA inhibition has not been demonstrated so far. Here we determined the role of PLM phosphorylation sites (Ser63 and Ser 68) by measuring the effect of PKA and PKC activation on NKA function in HeLa cells stably expressing rat NKA-␣ 1 with acute expression of PLM. HeLa cells have the advantage of being easy to culture and less problematic (compared to cardiac myocytes) for gene manipulation. For [Na ϩ ] i measurements, fluorescence signals were collected from a region containing ϳ20 cells. Although we did not use a fluorescent tag attached to PLM to prevent contamination of the SBFI signal, parallel adenoviral infections with GFP included in the vector (but not fused to PLM) showed a high expression efficiency (Ͼ90%) and Western blot data indicated that the level of PLM was comparable whether infected alone or in the vector with GFP. Because only ϳ90% of the cells used for [Na ϩ ] i measurements expressed PLM, the effect of PLM on NKA function measured here might be slightly underestimated. However, this does not affect the validity of our conclusions.
WT and mutant (S63A, S68A, and S63A-S68A double mutant) PLM were used here to determine how NKA was regulated by PLM upon Ser68 and Ser63 phosphorylation. WT and all PLM mutants inhibited NKA by decreasing the apparent pump affinity for internal Na ϩ . This result is consistent with previous data in cardiac myocyte (2, 6, 11) , Hela cells (12) , and oocytes (1, 4) .
Activation of PKA and PKC shifted the apparent affinity for internal Na ϩ of rat NKA-␣ 1 in HeLa cells expressing WT PLM by ϳ4 mM. This is comparable to what we found in mouse cardiac myocytes (2, 6) . However, in a previous study (11), we found that PLM phosphorylation by PKC increased NKA activity, but via increasing V max , while the affinity for internal Na ϩ was not changed. The reasons for the lack of K 0.5 effect in that study are unclear. PKA and PKC activation did not affect NKA K 0.5 in HeLa cells without PLM or in cells expressing PLM with the Ser63 and Ser68 sites rendered unphosphorylatable (AA PLM). Thus, if PKA and/or PKC phosphorylate PLM at other sites, this has no effect on NKA transport function in HeLa cells.
PKC readily phosphorylates WT PLM at both Ser63 and Ser68 sites and mutant S63A and S68A PLM at the nonmutated site in HeLa cells (Fig. 5, A-C) . Phosphorylation at only one site is sufficient for increasing the NKA affinity for internal Na ϩ , as demonstrated in experiments with the S63A and S68A mutants, and the effect does not seem additive. Thus PLM phosphorylation at either Ser 63 or Ser68 is both necessary and sufficient to relieve the PLM-induced NKA inhibition.
PKA and PKC activation did not significantly affect the NKA maximum pumping rate under any condition. A previous study using 86 Rb uptake (16) found that PKA and PKC modestly reduce the NKA V max in HeLa cells expressing rat NKA-␣ 1 (by 22 and 27%, respectively). This effect might be due to NKA internalization and might have been enhanced in that study by the stronger kinase activation (1 M PMA for PKC; forskolin plus IBMX for PKA) or their use of monensin as an ionophore. The lack of PKA and PKC effects on V max found here is in agreement with our own previous data in cardiac myocytes (2) and other data in oocytes (1) that show no V max effects for the ␣ 1 -isoform of NKA. Both studies found, however, that PKC activation increases the V max of the NKA-␣ 2 , which may explain our previous finding that PDBu increases the total NKA V max in mouse cardiac myocytes (11) .
In summary, we showed that 1) PLM phosphorylation at either Ser68 or Ser63 is necessary to fully mediate the enhancement of rat NKA-␣ 1 activity induced by PKA and PKC activation; 2) PLM phosphorylation at other sites, if it occurs in HeLa cells, has no consequence on NKA function; and 3) PLM phosphorylation by PKC at either Ser63 or Ser68 is sufficient and redundant in relieving the NKA inhibition by PLM.
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